欢迎访问《解剖学报》官方网站！今天是
English
小檗碱对胆碱-蛋氨酸缺乏饮食诱导非酒精性脂肪性肝炎小鼠肝组织巨噬细胞表型转化的调节作用
张慧芹 刘泽洲 续畅 刘新 娄金丽 李健 牛建昭 郝钰*
解剖学报 ›› 2014, Vol. 45 ›› Issue (5) : 633-638.
小檗碱对胆碱-蛋氨酸缺乏饮食诱导非酒精性脂肪性肝炎小鼠肝组织巨噬细胞表型转化的调节作用
Regulating effect of berberine on macrophage phenotype transformation in hepatic tissue of mice with methionine-choline deficiency diet induced non-alcoholic steatohepatitis
目的 观察小檗碱对胆碱-蛋氨酸缺乏（MCD）饮食诱导非酒精性脂肪性肝炎（NASH）模型小鼠肝组织巨噬细胞M1、M2表型转化的作用。
方法 雄性C57BL/6小鼠40只随机分为4组（每组10只）：正常组（饲喂常规饲料），模型组（饲喂MCD饲料），罗格列酮干预组（30mg/kg）和小檗碱干预组（150mg/kg），采用预防给药方式，连续2周。通过组织病理学评分评估动物模型及药物疗效；采用ELISA法检测血清肿瘤坏死因子-α（TNF-α）、白细胞介素（IL-6）及IL-10水平；流式细胞术检测肝组织中M1、M2型巨噬细胞的数量和比值。结果 罗格列酮和小檗碱可显著改善MCD饮食诱导小鼠NASH的病理程度，显著下调血清中TNF-α水平（P<0.05），显著上调血清中IL-10水平（P<0.05），显著降低肝组织中M1型巨噬细胞及增加M2型巨噬细胞的数量，降低M1/M2比值（P<0.01）。 结论 小檗碱对MCD饮食诱导小鼠NASH有较好改善作用，其部分药理机制为：调节肝组织中巨噬细胞表型转化，增加M2型巨噬细胞比例，上调抗炎细胞因子的分泌。
Objective To determine the efficacy of berberine in the treatment of non-alcoholic steatohepatitis (NASH), and to investigate the regulating effect on macrophage phenotype transformation in hepatic tissue on methionine-choline deficiency (MCD) diet induced NASH mice. Methods Fourty male C57BL/6 mice were randomly divided into 4 groups (10 mice per group): the normal group (fed with normal diet), the NASH model group (fed with MCD diet), rosiglitazone treatment group (30mg/kg) and berberine treatment group (150mg/kg). Drugs were adopted in the preventive intervention method for 2 weeks. The hepatic histopathological method was adopted to evaluate the drug therapeutic effect. The serum levels of tumor necrosis factor-α(TNF-α), interleukin(IL)-6, and IL-10 were examined with ELISA method. M1 and M2 phenotype were detected by flow cytometry. Results The results showed berberine improved the degree of hepatic histopathology. Berberine not only reduced the level of TNF-α, but also increased the level of IL-10 in serum on NASH mice significantly (P<0.05). Flow cytometry data indicated that berberine decreased M1 type macrophages and increased M2 type macrophages in liver tissue. The ratio of M1/M2 was significantly decreased in berberine and rosiglitazone treated group (P<0.01). Conclusion Berberine may improve the hepatic pathological process in MCD diet induced NASH model possibly through modulating macrophage phenotype transformation, i.e. The ratio of M2 type is more than M1 type in hepatic tissue, and increasing anti-inflammatory cytokines.
小檗碱 / 非酒精性脂肪性肝炎 / 巨噬细胞 / 表型转化 / 流式细胞术 / 小鼠
Berberine / Non-alcholic steatohepatitis / Macrophage / Phenotype transformation / Flow cytometry / Mouse
［1］Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China ［J］. J Hepatol, 2009，50(1): 204-210.
［2］Shi JP, Fan JG. Effects of hepatoprotectants in the treatment of nonalcoholic fatty liver disease ［J］. World Clinical Drugs, 2010, 31 (9): 526-531. (in Chinese)
施军平，范建高. 保肝抗炎药物在非酒精性脂肪性肝病治疗中的作用［J］. 世界临床医药， 2010, 31 (9): 526-531.
［3］Neyrinck AM, Cani PD, Dewulf EM, et al. Critical role of Kuffer cells in the management of diet-induced diabetes and obesity ［J］. Biochem Biophys Res Commun, 2009, 385 (3):351-356.［4］Maina V, Sutti S, Locatelli I, et al. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice ［J］. Clin Sci, 2012, 122(11):545-553.
［5］Bouhlel MA, Derudas B, Rigamonti E, et al. PPAR-gamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties ［J］. Cell Metlab, 2007, 6(2): 137-143.
［6］Charo IF, Macrophage polarization and insulin resistance: PPAR-gamma in control ［J］. Cell Metlab, 2007, 6(2):96-98.
［7］Wu CW, Chu ES, Lam CN, et al. PPAR-gamma is essential for protection against nonalcoholic steatohepatitis ［J］. Gene Ther, 2010, 17 (6): 790-798.
［8］Nan, YM, Fu N, Wu WJ, et al. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice［J］. Scand J Gastroenterol, 2009, 44(3): 358-365.
［9］Kallwitz ER, McLachlan A, Cotler SJ. Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease ［J］. World J Gastroeuterol, 2008, 14 (1): 22-28.
［10］Xing LJ, Zhang L, Liu T, et al. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver［J］. Eur J Pharmacol, 2011, 668 (3):467-471.
［11］Yang QH, Hu SP, Zhang YP, et al. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats［J］. Chin J Integr Med, 2011, 17(3):205-211.
［12］Li J, Hao Y, Zhang YL, et al. Berberine inhibits tumor-associated macrophages in subcutaneous tumor of mice ［J］. Chinese Journal of Histochemistry and Cytochemistry, 2011, 20(3): 203-206. (in Chinese)
李健, 郝钰, 张玉丽, 等. 小檗碱对CT26皮下移植瘤组织中肿瘤相关巨噬细胞的影响［J］.中国组织化学与细胞化学杂志,2011,20(3): 203-206.
［13］Su DM, Zhu-Ge L, Li J, et al. A mouse model of nonalcoholic steatohepatitis induced by feeding a methionine-choline-deficient diet: establishment and dynamic monitoring ［J］. World Chinese Journal of Digestology, 2011, 19 (11): 1122-1127. (in Chinese)
苏冬梅,诸葛丽,李健,等. 蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝炎小鼠模型的建立及动态监测 ［J］. 世界华人消化杂志, 2011,19(11): 1122-1127.
［14］Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease ［J］. Hepatology, 2005, 41(6): 1313-1321.
［15］Jerrold MO, Christopher KG. Macrophages, inflammation and insulin resistance ［J］. Annu. Rev. Physiol, 2010, 72(1): 219-246.
［16］Zhang YT, An W. Role of liver innate immune cells in nonalcoholic fatty liver disease［J］. World J Gastroeuterol, 2010, 16 (37): 4652-4660.
［17］Oh DY, Morinaga H, Talukdar S, et al. Increased macrophage migration into adipose tissue in obese mice［J］. Diabetes, 2012, 61(2): 346-354.
［18］Chawla A. Control of macrophage activation and function by PPARs ［J］. Circ Res, 2010, 106(10): 1559-1569.
［19］Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance［J］. Nature, 2007, 447 (7148): 1116-1120.
［20］Younossi ZM. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis［J］. Aliment Pharmacol Ther, 2008, 28 (1) : 2-12.
［21］Jeong HW, Hsu KC, Lee JW, et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages［J］. Am J Physiol Endocrinol Metab, 2009, 296(4): E955-964.
［22］Chen FL, Yang ZH, Liu Y,et al. Berberine inhibits the expression of TNF-αlpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPAR-gamma pathway［J］. Endocrine, 2008, 33(3): 331-337.
雷公藤肝损伤的机制;教育部创新引智基地项目
/
| 〈 |
|
〉 |
